| 英文別名： |
Ticagrelor;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol;(1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;AR-C 126532XX;AZD 6140;AZD-6140;Brilinta;Brilique;TICARGRELOR;Ticagrelor Impurity 81 |
| 中文別名： |
替卡格雷;替卡格雷雜質(zhì);阿索卡諾;硫秋水仙苷;替格瑞洛;替格瑞洛單晶、依折麥布單晶、利伐沙班單晶、索非布韋單晶;替卡格雷(Anticogulant);替卡格雷標(biāo)準(zhǔn)品;替卡格雷標(biāo)準(zhǔn)品及雜質(zhì);替卡格雷及其中間體;替卡格雷藥;替卡格雷雜質(zhì)及標(biāo)準(zhǔn)品;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-二氟苯基)環(huán)丙基]氨基]-5-丙硫基三唑并[4,5-d]嘧啶-3-基]-5-(2-羥乙氧基)-1,2-環(huán)戊二醇;(1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-二氟苯)環(huán)丙基]氨基}-5-(丙基硫氧嘧啶)-3H-[1,2,3]-三唑磷[4,5-D]嘧啶-3-基]-5-(2-羥乙基)環(huán)戊烷-1,2-二醇;提卡格雷;替格瑞洛雜質(zhì)81 |
.png)
滬公網(wǎng)安備 31011502020044號(hào)
危險(xiǎn)化學(xué)品經(jīng)營(yíng)許可證
水濤